A carregar...
All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism
Oral anticoagulants used for the primary treatment of venous thromboembolism (VTE) include warfarin and the more recently introduced direct oral anticoagulants (DOACs), including rivaroxaban, apixaban, dabigatran, and edoxaban. Information on the comparative safety of these medications in routine cl...
Na minha lista:
| Publicado no: | Thromb Haemost |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172009/ https://ncbi.nlm.nih.gov/pubmed/30103250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1668521 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|